Medicine Producers and Importers Union (MPI Union) of Armenia demands tightening of laws that regulate import and export of drugs, head of the Union said.
As Samvel Zakaryan told a press conference on March 29, amendment to the decision “On approval of import and export of drugs” passed by the government back in March 2011, resulted in emergence of counterfeit medicine such as Actovegin Forte 200 mg, Series 1069391 and 10677398, Concor 5 mg, Series 135628 and Concor Cor 2,5 mg, Series 133703 by Nycomed pharmaceutical company.
According to Mr. Zakaryan, government amendments enabled importers to sell drugs without registration in relevant research center.
“We repeatedly addressed the authorities with a request to reconsider the decision. This time, too, we have issued a letter both to the government and security institutions to take steps aimed at withdrawal of these drugs from circulation.
Head of the MPI Union, however, dismissed linkage of the problem to market monopolization.
According to him, the problem, instead, is related to the fact that the legislation doesn’t stipulate use of a differential mark on the drug package that would enable the consumer to differentiate registered medication from the unregistered one.
